← FDA Drug Approvals (Drugs@FDA)

APIXABAN

NDA · New Drug Application · Sponsor: LUPIN · Approved 2026-09-25

Drug application

FDA Application #

NDA220446

Application type

New Drug Application

Brand name

APIXABAN

Generic name

Apixaban

Active ingredients

APIXABAN

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

LUPIN

First approval

2026-09-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown